CDX Company

CDX Company: A Comprehensive Overview

Company Overview

Founding Date and Background

CDX Company, also known as Cardiex Limited, was founded on December 6, 2013. Originally established under the name Atcor Medical Holdings Limited, the company has evolved to focus on global health technology, specifically targeting hypertension, cardiovascular disease, and other vascular health disorders.

Parent Company/Ownership Structure

Cardiex Limited operates as a limited liability company and is owned by Cyndx Holdco, Inc., which serves as the sole member. This ownership structure allows Cardiex to maintain a focused approach to its business operations and strategic goals.

Headquarters Location

The headquarters of CDX Company is located at 485 Lexington Ave, Suite 400, New York, NY 10017, USA. This strategic location places the company in a major financial hub, allowing for better access to investors and healthcare professionals.

Global Business Scope

CDX Company operates on a global scale, with manufacturing and research and development facilities located in Sydney, Australia. The company also has a significant presence in the United States, with its American subsidiary, Atcor, headquartered in Naperville, Illinois. Furthermore, CDX has expanded its business development efforts into Asian markets, particularly in Shanghai, China.

Main Regulatory Bodies

Cardiex Limited is regulated by various bodies, including the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA). Additionally, it is recognized by the Ministry of Economy and Finance of Cambodia and the Securities and Exchange Commission of Cambodia, which oversees its operations in that region.

Back to top

Company History and Development

Key Milestones

Since its inception, CDX Company has achieved several significant milestones. The rebranding from Atcor Medical to Cardiex Limited marked a pivotal moment in its history, allowing the company to broaden its focus on cardiovascular health technologies.

Business Expansion Journey

Over the years, CDX has expanded its product offerings and market reach. The company has developed innovative technologies aimed at improving vascular health and has established partnerships with various healthcare institutions to enhance its service delivery.

Customer Base Growth

CDX has experienced steady growth in its customer base, primarily due to its commitment to research and development. The company's focus on hypertension and cardiovascular disease has attracted a diverse clientele, including healthcare providers, researchers, and patients across different demographics.

Platform Development History

The development of CDX's technology platforms has been crucial to its success. The company has invested heavily in research and development, leading to the creation of advanced diagnostic tools and health management systems that cater to a global audience.

Important Awards or Recognitions Received

Throughout its journey, CDX has received various accolades for its contributions to healthcare technology. These recognitions underscore the company's dedication to innovation and its impact on improving health outcomes.

Back to top

Trading Services Offered

Forex Trading Options

CDX Company provides a range of trading services, including forex trading. The company offers a selection of currency pairs, enabling traders to engage in the foreign exchange market effectively. Specific details about the number of currency pairs offered are not disclosed.

Stock Trading Options

In addition to forex, CDX allows clients to trade stocks. The platform provides access to various equities, enabling investors to diversify their portfolios.

CFD Trading Products

The company also offers Contracts for Difference (CFDs), allowing traders to speculate on price movements without owning the underlying asset. This flexibility is appealing to many investors looking to capitalize on market fluctuations.

Other Financial Instruments

CDX's trading services extend to other financial instruments, including cryptocurrencies and commodities. This diverse offering enables clients to explore various investment opportunities within a single platform.

Special Services or Unique Advantages

CDX Company differentiates itself through its advanced trading technologies and user-friendly interfaces. The company emphasizes education and support for its clients, providing resources to help them make informed trading decisions.

Back to top

Regulatory and Legal Background

Detailed Regulatory Information

CDX Company is subject to regulation by several bodies, including:

• U.S. Securities and Exchange Commission (SEC)
• Financial Industry Regulatory Authority (FINRA)
• Ministry of Economy and Finance of Cambodia
• Securities and Exchange Commission of Cambodia

Legal Entity Structure by Region

The legal entity structure of CDX varies by region, with the company operating as a limited liability company in the United States and maintaining compliance with local regulations in markets like Cambodia.

Client Fund Protection Measures

CDX is committed to ensuring the safety of client funds. The company employs various measures, such as segregated accounts and compliance with regulatory requirements, to protect investor assets.

Countries/Regions Served

CDX operates in multiple countries, including the United States, Australia, and Cambodia, with plans for further expansion into Asian markets.

Compliance History

The company maintains a strong compliance record, with no significant regulatory disclosures reported. CDX encourages investors to conduct thorough due diligence before engaging with their services.

Back to top

Competitive Landscape

Main Competitors

CDX Company faces competition from several key players in the health technology and trading sectors, including:

1. Atcor Medical
2. Medtronic
3. Philips Healthcare
4. Abbott Laboratories
5. Boston Scientific

Positioning in the Industry

CDX positions itself as a leader in cardiovascular health technology, focusing on innovative solutions that address hypertension and related disorders. Its trading platform aims to provide a comprehensive suite of services to meet the diverse needs of investors.

Market Differentiation Factors

CDX differentiates itself through its commitment to research and development, a robust technological infrastructure, and a focus on customer education. The company's ability to adapt to market trends and regulatory changes further enhances its competitive edge.

Back to top

In conclusion, CDX Company, through its innovative approach and dedication to healthcare technology, continues to make significant strides in the industry. With a solid regulatory framework and a commitment to client satisfaction, CDX is well-positioned for future growth and success. For more information on CDX and its offerings, learn more.